Current trends in bariatric surgery
https://doi.org/10.18705/3034-7270-2025-1-2-103-111
Abstract
Bariatric surgery remains the most effective method of treating morbid obesity, however, modern approaches require the integration of pharmacotherapy and multidisciplinary support to achieve sustainable results. The purpose of this literature review was to analyze current trends in bariatric surgery, evaluate the effectiveness of various surgical interventions, as well as the role of pharmacotherapy and standardization of protocols in improving the quality of treatment. A review of randomized clinical trials, meta-analyses, and registry data on the outcomes of laparoscopic longitudinal gastric resection (PRG), the use of GLP-1 agonists and double GIP/GLP-1 agonists, multidisciplinary patient management, and the implementation of ERAS protocols has been performed. Longitudinal gastric resection provides 60–70 % of excess body weight loss (EWL) within 5–7 years and remission of type 2 diabetes in 50–60 % of cases, comparable with the results of gastric bypass surgery. For patients with superobesity, this technique remains highly effective and safe. A multidisciplinary approach helps to reduce the risk of relapse and increase the effectiveness of therapy. Pharmacotherapy using semaglutide and tirzepatide is effective both before and after surgery, reducing the frequency of weight loss. The standardization of treatment protocols has reduced the incidence of complications to 1.06 % and shortened the duration of hospitalization. Laparoscopic longitudinal gastric resection remains the basic method of bariatric surgery, the effectiveness of which is significantly increased when combined with pharmacotherapy and comprehensive multidisciplinary management. The use of digital technologies and the standardization of treatment protocols contribute to increased safety and improved longterm treatment outcomes for patients with morbid obesity.
About the Authors
A. E. Neimark
Almazov National Research Medical Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Neimark Aleksandr E. – Candidate of Medical Sciences, Associate Professor, Leading Researcher
St. Petersburg
S. E. Lapshina
Almazov National Research Medical Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Lapshina Sofya E. – Surgeon, Assistant Professor
St. Petersburg
References
1. World Health Organization. Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed: 03.05.2025).
2. NCD Risk Factor Collaboration. Worldwide trends in obesity and metabolic health. Lancet. 2024;403(10392):874–885.
3. Syn N.L., Cummings D.E., Wang L., et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a meta-analysis. Lancet. 2021;397(10287):1830–1839.
4. Aminian A., Zajichek A., Subramanian S., et al. Metabolic surgery and cardiovascular outcomes in type 2 diabetes: a matched cohort study. JAMA. 2022;328(11):1089–1097.
5. Ruban A., Stoenchev K., Ashrafian H. Current treatments for obesity. Clin Med (Lond). 2019;19(3):205–212.
6. Wilding J.P.H., Batterham R.L., Davies M., et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002.
7. Angrisani L., Santonicola A., Iovino P., et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–1832.
8. Franken R., Laar A.. Evidence-based classification for post-bariatric weight regain from a benchmark registry cohort of 18,403 patients and comparison with current criteria. Obes Surg. 2023;33(7):1–9.
9. Peterli R., Borbely Y., Zuber M., et al. Sleeve gastrectomy vs Roux-en-Y gastric bypass for morbid obesity: 7-year results of a randomized clinical trial (SLEEVEPASS). Ann Surg. 2018;268(3):459–466.
10. Lei Y., Lei X., Chen G., et al. Update on comparison of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass: a systematic review and meta-analysis of weight loss, comorbidities, and quality of life at 5 years. BMC Surg. 2024;24:219.
11. Johnson M.K., Lee Y.S., Wong J., et al. Sleeve gastrectomy in patients with BMI ≥ 60: safety and efficacy. Obes Surg. 2023;33(2):543–549.
12. Brown J.A., Nelson L.G., Smith K.R., et al. Two-year outcomes of laparoscopic sleeve gastrectomy in patients with BMI > 50. Surg Obes Relat Dis. 2020;16(5):668–675.
13. Aminian A., Zajichek A., Arterburn D.E., et al. Metabolic outcomes after bariatric surgery. BMC Surg. 2024;24(1):15.
14. Smith B.R., Markovic T.P., Chen M.K., et al. Long-term remission of type 2 diabetes after bariatric surgery. Diabetes Care. 2023;46(2):320–328.
15. Lee Y.W., Kim E.S., Kim J.H., et al. Five-year outcomes of bariatric surgery: meta-analysis. Obes Surg. 2024;34(1):120–129.
16. Ghusn W., Zeineddine J., Betancourt R.S. et al. Advances in Metabolic Bariatric Surgeries and Endoscopic Therapies: A Comprehensive Narrative Review of Diabetes Remission Outcomes. Medicina. 2025;61(2):350.
17. Peterli R., Borbely Y., Kopp H.P., et al. Randomized clinical trial comparing LSG and RYGB: 7-year follow-up. Ann Surg. 2023;277(2):273–279.
18. Lee W.J., Ser K.H., Lee Y.C., et al. Safety and complications of bariatric surgery: review of national data. Obes Surg. 2021;31(11):4767–4775.
19. Ramos A.C., Silva-Júnior W.S., Santo M.A., et al. Metabolic improvements after mini-gastric bypass and single anastomosis duodeno-ileal bypass with sleeve gastrectomy: systematic review. Surg Obes Relat Dis. 2022;18(3):340–350.
20. Kumar N., Yadav R., Singh P., et al. Nutritional deficiencies after bariatric procedures: a comparative study. Clin Nutr. 2023;42(4):823–831.
21. Salminen P., Helmiö M., Ovaska J., et al. Complications and reoperations after bariatric surgery: a registry study. Obes Surg. 2022;32(1):117–124.
22. Calì B., Pellegrino M., Di Minno M.N., et al. Long-term nutritional consequences after single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): review. Obes Surg. 2024;34(2):457–465.
23. Sharaiha R.Z., Shikora S., White K.P., et al. Summarizing Consensus Guidelines on Obesity Management: A Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO). J Clin Gastroenterol. 2023;57(10):967–976.
24. Sockalingam S., Leung S.E., Wnuk S., et al. Psychiatric Management of Bariatric Surgery Patients: A Review of Psychopharmacological and Psychological Treatments and Their Impact on Postoperative Mental Health and Weight Outcomes. Psychosomatics. 2020;61(5):498–507.
25. Parnell K.E., Philip J., Billmeier S.E., Trus T.L. The effects of using telemedicine for introductory bariatric surgery seminars during the COVID-19 pandemic. Surg Endosc. 2023 Jul;37(7):5509–5515. DOI: 10.1007/s00464-022-09640-w.
26. Guan Z., Li H., Liu R., et al. Artificial intelligence in diabetes management: Advancements, opportunities, and challenges. Cell Rep Med. 2023;4(10):101213. DOI: 10.1016/j.xcrm.2023.101213.
27. Gollisch K.S.C., Raddatz D. Endoscopic intragastric balloon: a gimmick or a viable option for obesity? Ann Transl Med. 2020;8(Suppl 1):S8. DOI: 10.21037/atm.2019.09.67.
28. Khera R., Murad M.H., Chandar A.K., et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–2434.
29. Jastreboff A.M., Aronne L.J., Ahmad N.N., et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216.
30. MacVicar E., Lucocq J., Geropoulos G., et al. The Role of Preoperative Weight Loss Interventions on Long-Term Bariatric Surgery Outcomes: A Systematic Review. Journal of Clinical Medicine. 2025;14(9):3147.
31. Salukhov V.V., Galstyan G.R., Khalimov Yu.Sh., et al. Practical use of semaglutide: from evidence-based studies to expert decisions. Medical Council. 2025;19(6):14–29. (In Russ.)
32. Neimark A.E., Lapshina S.E., Shulyakovskaya A.S. Dietary recommendations for bariatric patients using specialized nutrition. Obesity and Metabolism. 2024;21(3):325–330. DOI: 10.14341/omet13119. (In Russ.)
33. Sanyal A.J., Newsome P.N., Kliers I., et al. Phase 3 trial of semaglutide in metabolic dysfunction–associated steatohepatitis. N Engl J Med. 2025;392(21):2089–2099. DOI: 10.1056/NEJMoa2413258.
34. Schiavo L., Santella B., Mingo M., et al. Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity. Nutrients. 2025;17(7):1216. DOI: 10.3390/nu17071216.
35. Lean M.E.J., Leslie W.S., Barnes A.C. et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT openlabel, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7(5):344–355. DOI: 10.1016/S2213-8587(19)30068-3.
36. Courcoulas A.P., Christian N.J., Belle S.H., et al. Weight change and health outcomes 3 years after bariatric surgery. JAMA. 2013;310(22):2416–2425.
37. Peterli R., Wölnerhanssen B., Peters T., et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: a randomized clinical trial. JAMA. 2018;319(3):255–265.
38. Noria S.F., Shelby R.D., Atkins K.D., et al. Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment. Curr Diab Rep. 2023;23(3):31–42. DOI: 10.1007/s11892-023-01498-z.
39. Çalık B.N., Dotan I., Dicker D. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels. Int J Obes. 2025;49(3):412–417.
40. Vidmar A.P., Vu M.H., Martin M.J., et al. Early Reinitiation of Obesity Pharmacotherapy Post Laparoscopic Sleeve Gastrectomy in Youth: A Retrospective Cohort Study. Obes Surg. 2025;35(2):406–418.
41. Zhou B., Ji H., Liu Y., et al. ERAS reduces postoperative hospital stay and complications after bariatric surgery: a retrospective cohort study. Medicine (Baltimore). 2021;100(47):e27831.
42. Almaski I.E.M., Alalwani Y.J., Alshammari R.S., et al. Component-based approach of enhanced recovery after surgery protocols in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials. Metabolism Open. 2025;27:100376.
43. Khatsiev B.B., Gomon Yu.M., Spichakova E.A., et al. Safety assessment of bariatric surgery in the Russian Federation according to the Russian National Bariatric Registry. Endoscopic Surgery. 2025;31(1):5–14. (In Russ.)
44. Khatsiev B.B., Akhmetov A.D., Kuzminov A.N., et al. Bareoreg: Russian national bariatric registry. Endoscopic Surgery. 2019;25(4):23–33. (In Russ.)
45. Eisenberg D., Shikora S.A., Aarts E., et al. American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345–1356. DOI: 10.1016/j.soard.2022.08.013.
46. Sauro K.M., Smith C., Ibadin S., et al. Enhanced Recovery After Surgery Guidelines and Hospital Length of Stay, Readmission, Complications, and Mortality: A Meta-Analysis of Randomized Clinical Trials. JAMA Netw Open. 2024;7(6):e2417310. DOI: 10.1001/jamanetworkopen.2024.17310.
47. Vasyukova O.V., Okorokov P.L., Malievskiy O.A., et al. Clinical guidelines «Obesity in children». Obesity and metabolism. 2024;21(4):439–453. (In Russ.)
Review
For citations:
Neimark A.E., Lapshina S.E. Current trends in bariatric surgery. Russian surgical journal. 2025;1(2):103-111. (In Russ.) https://doi.org/10.18705/3034-7270-2025-1-2-103-111
Views:
91
Email this article 